drugset / Trial / NCT01940718

Androgen Regulation of Priapism in Sickle Cell Disease

NCT01940718

Phase 0 Withdrawn Johns Hopkins University
NaSingle-groupOpen-labelTreatment

Summary

It is believed that when androgen (testosterone) levels are below normal there is a disturbance of normal bodily functioning that is associated with priapism in some men. Conversely, it is believed that testosterone replacement will improve the condition of priapism when the testosterone levels are brought to normal. In turn, this will also improve psychological well being in men with sickle cell disease (SCD).

Timeline

Start
2014-03
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 20.25 mg Other